Home>>Peptides>>β-Casomorphin, human (Human β-casomorphin 7)

β-Casomorphin, human (Human β-casomorphin 7) (Synonyms: Human β-casomorphin 7)

Catalog No.GC33784

is an opioid peptide, acts as an agonist of opioid receptor.

Products are for research use only. Not for human use. We do not sell to patients.

β-Casomorphin, human (Human β-casomorphin 7) Chemical Structure

Cas No.: 102029-74-3

Size Price Stock Qty
In stock
In stock
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

β-Casomorphin, human is an opioid peptide, acts as an agonist of opioid receptor.

β-Casomorphin, human (TyrPro-Phe-Val-Glu-Pro-Ile) is also called human B-casein-(51-57), with the sequenceequivalent to bovine B-casein-(60-66) (Tyr-ProPhe-Pro-G]y-Pro-Ile or B-casomorphin-7)[1]. β-Casomorphin, human (100 μM) increases the expression of rat mucin (rMuc)2 and rMuc3 but not rMuc1, rMuc4, and rMuc5AC in rat DHE cells, also elevates increased MUC5AC mRNA levels[2].

[1]. Brantl V. Novel opioid peptides derived from human beta-casein: human beta-casomorphins. Eur J Pharmacol. 1984 Oct 30;106(1):213-4. [2]. Zoghbi S, et al. beta-Casomorphin-7 regulates the secretion and expression of gastrointestinal mucins through a mu-opioid pathway. Am J Physiol Gastrointest Liver Physiol. 2006 Jun;290(6):G1105-13.


Review for β-Casomorphin, human (Human β-casomorphin 7)

Average Rating: 5 ★★★★★ (Based on Reviews and 39 reference(s) in Google Scholar.)

5 Star
4 Star
3 Star
2 Star
1 Star
Review for β-Casomorphin, human (Human β-casomorphin 7)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.